Dr. Melian is the Chief Medical Officer & Head of Global Medical Sciences for an Elevate Portfolio Company.
Prior to ElevateBio, Dr. Melian was an SVP in both Global Clinical Development and Medical Sciences at Alexion Pharmaceuticals. While there, the company achieved record timelines across clinical development including Ultomiris (a >500 patients rare disease development program fully executed from IND to filing in
Education & Accomplishments
Dr. Melian graduated cum laude with degrees in Molecular Biophysics and Biochemistry and in Medicine from Yale University. He also has a background in DNA transcription and repair. Prior to his industry work, Dr. Melian practiced Medicine and conducted Basic Immunology Research at The Brigham and Women’s Hospital in Boston.
Interested in working with people like Agustin? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.